Skip to Main Content

Author Details

Michael C Haffner
Fred Hutchinson Cancer Center
2005
126
35
PMIDPaper TitleJournal TitlePublished Year
37850574Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.J Pathol2024
36309102Genomic Characterization of Prostatic Basal Cell Carcinoma.Am J Pathol2023
37591951KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.Nat Cell Biol2023
37582946An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading.NPJ Precis Oncol2023
37609344Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations.bioRxiv2023
37973913SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.Nat Commun2023
37815914MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.Cell Rep2023
37922910Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.Cancer Cell2023
37531417Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.Sci Transl Med2023
37352376Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.Cancer Res2023
37084735Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.Cancer Cell2023
37041154Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.Nat Commun2023
36853945Metastasis from the tumor interior and necrotic core formation are regulated by breast cancer-derived angiopoietin-like 7.Proc Natl Acad Sci U S A2023
36779357Clinical, pathologic, and molecular features of amphicrine prostate cancer.Prostate2023
36399432Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.Cancer Discov2023
36564459Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.Prostate Cancer Prostatic Dis2023
36821396Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.JCI Insight2023
35272673SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples.Clin Epigenetics2022
35603787Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.JCI Insight2022
35695870Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.Clin Cancer Res2022
35452513Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.Mol Cancer Res2022
35552660Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2022
36109521Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Nat Commun2022
36337169Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.Cancer Res Commun2022
36309296Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8.Hum Pathol2022
35968526Prostate multi-parametric magnetic resonance imaging appearance of diffuse adenosis of the peripheral zone (DAPZ).Urol Case Rep2022
36206341Oncogenic role of a developmentally regulated <i>NTRK2</i> splice variant.Sci Adv2022
36050516Reversible epigenetic alterations regulate class I HLA loss in prostate cancer.Commun Biol2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
35157907Whole Genome Sequencing Reveals Independent Clonal Origin of Bilateral Testicular Germ Cell Tumors in 2 Patients with Pure Seminoma.Urology2022
35243412Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymes.Cell Rep Med2022
34999736Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130.Oncogene2022
33002920Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.Am J Surg Pathol2021
33576154Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases.Mol Oncol2021
33870509Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.J Pathol2021
33724955Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.JCI Insight2021
35122025Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression.Nat Cancer2021
34877933Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.JCI Insight2021
34431104Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.J Pathol2021
34402095Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.Prostate2021
34479754Divining Harm-Benefit Tradeoffs of Magnetic Resonance Imaging-targeted Biopsy.Eur Urol2021
34128479Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.J Clin Invest2021
34341114Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer.Proc Natl Acad Sci U S A2021
34312180RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.Cancer Res2021
34373091Molecular Pathology of Prostate Cancer.Surg Pathol Clin2021
34193566TGM4: an immunogenic prostate-restricted antigen.J Immunother Cancer2021
33998604Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.J Clin Invest2021
33199493Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.Clin Cancer Res2021
33328650Genomic and phenotypic heterogeneity in prostate cancer.Nat Rev Urol2021
32468444Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.Cell Oncol (Dordr)2020
  • 1 - 50 of 126

Recommended Authors

Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 21
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 32
Kyung Park
New York University Langone Health
Career Start Year 2010
Number of shared co-authors 18
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 47
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 38
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 27
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 35
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 19
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 11
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 9
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 22
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 22
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 9
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 6
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 53
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 32
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 44
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 12
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 37
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 39
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 10
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 1
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 50
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 24
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 12
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 3
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 46
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 45
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 33
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 63

Collaborators

Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 43
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 21
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 18
Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers 18
Eva Corey
University of Washington School of Medicine
Co-authored papers 15
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 14
Colm Morrissey
Co-authored papers 12
Lawrence D True
University of Washington School of Medicine
Co-authored papers 8
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 6
Jin-Yih Low
Fred Hutchinson Cancer Center
Co-authored papers 6
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 5
Stephen R Plymate
University of Washington
Co-authored papers 5
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 4
Jianfeng Xu
Co-authored papers 4
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 4
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 4
Elahe A Mostaghel
University of Washington
Co-authored papers 4
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 3
David A Quigley
University of California-San Francisco
Co-authored papers 3
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 3
Elai Davicioni
Veracyte Inc.
Co-authored papers 3
Rafael A Irizarry
Dana-Farber Cancer Institute
Co-authored papers 3
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 3
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Co-authored papers 3
Ashley E Ross
Northwestern University
Co-authored papers 3
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Co-authored papers 3
Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 3
Release 1.2